No Data
No Data
No Data
No Data
No Data
We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Can Stay On Top Of Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, whe
Simply Wall StMar 21 19:00 ET
Wang Yanping, the majority shareholder of Jianzhijia (605266.SH), reduced his holdings by 232,000 shares in total, and the reduction period expired
Jianzhijia (605266.SH) issued an announcement. Wang Yanping, the shareholder of the company holding more than 5% of the shares, passed the bidding and trading system...
Zhitong FinanceFeb 29 03:21 ET
Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Most Bullish Insider, CEO Bo Lan Must Be Pleased With the Recent 15% Gain
Key Insights Insiders appear to have a vested interest in Jianzhijia Pharmaceutical Chain Group's growth, as seen by their sizeable ownership A total of 4 investors have a majority stake in the comp
Simply Wall StFeb 14 02:35 ET
JZJ Chain Drugstore Acquires 69 Pharmacies For 46 Million Yuan
JZJ Chain Drugstore (SHA:605266) has acquired 69 pharmacies from Sichuan Derentang Pharmaceutical Chain for 45.6 million yuan. The pharmacy chain operator expects the move to strengthen its presence i
MT NewswiresFeb 12 22:16 ET
Jianzhijia (605266.SH) plans to spend 45.6 million yuan to acquire 69 pharmacies in Derentang to strengthen intensive distribution in Chengdu
Zhitong Finance App News, Jianzhijia (605266.SH) announced that its wholly-owned subsidiary, Sichuan Jianzhijia Pharmacy Co., Ltd. (“Sichuan Jianzhijia”), signed a “Pharmacy Asset Acquisition Agreement” with its counterparty Sichuan Derentang Pharmaceutical Chain Co., Ltd. (“Derentang”) to acquire the store assets and operating interests (“target assets”) of 69 pharmacies in Derentang (hereinafter referred to as “target stores”) for 45.6 million yuan. Through the acquisition of target assets this time, Sichuan Jianzhijia has further strengthened its intensive distribution in Chengdu, Sichuan, and entered new regions to achieve rapid distribution and market acquisition
Zhitong FinanceFeb 8 03:44 ET
Do Jianzhijia Pharmaceutical Chain Group's (SHSE:605266) Earnings Warrant Your Attention?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Sometime
Simply Wall StJan 24 01:02 ET
No Data
No Data